The manifold significant events of 2022 will etch the year in the memories of many. Some will recall it as the year that marked the end of the COVID-19 pandemic, while others will remember the soaring egg prices and never-ending price hikes. In coming years, the historic inflation witnessed in 2022 could potentially also be remembered as a catalyst for changes in drug development that altered the types of drugs receiving investments and being brought to market.  

SDi is pleased to have recently published the latest edition of our flagship annual report, the 2023 SDi Global Assessment Report. As always, Global is the industry’s gold standard in market data for the laboratory instrumentation market. This year, the highest quality market information and forecasting is more important than ever; the market is strongly […]

As COVID-19 has spread from its origins to almost every corner of the world over the past six months, it has engendered major changes around the globe. The virus has caused a global slowdown due to lockdowns, supply chain disruptions, and reduced production levels, while also stimulating a vaccine race among pharmaceuticals and biotech companies. […]

Global Business COVID-19

The world has been justly preoccupied with the spread of COVID-19 throughout the world and its effects on human health. From a science standpoint, the life science and analytical instrumentation industry has responded to help combat the disease, by supporting research into better diagnosis, treatment, and prevention of the disease. From a business perspective, there […]

The American Association for Cancer Research (AACR) held its annual meeting March 29-April 3, 2019, in Atlanta, Georgia. The meeting, the largest cancer research conference in the world, brought together approximately 21,000 attendees from a diverse cross section of the cancer research community, with researchers and clinicians spanning academia, government, the pharmaceutical and biotechnology industries, […]